Related Experiment Video
Updated: Jul 9, 2025

Optimized Incorporation of Alkynyl Fatty Acid Analogs for the Detection of Fatty Acylated Proteins using Click Chemistry
Published on: April 9, 2021
Advances of Protein Palmitoylation in Tumor Cell Deaths
Xiangyi Lin1, Yuxuan Shi1, Yuxin Zhan1
1Department of Human Cell Biology and Genetics, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China.
Abstract:
In this comprehensive survey, we delve into the multifaceted role of palmitoylation across various cell death modalities in the oncological context, from its intricate correlations with tumorigenesis, steered by the Asp-His-His-Cys tetrapeptide motif (DHHC) family, to the counter-process of depalmitoylation mediated by enzymes like Palmitoyl protein thioesterase-1 (PPT1). Innovations in detection methodologies have paralleled our growing understanding, transitioning from rudimentary techniques to sophisticated modern methods. Central to our discourse are agents like Ezurpimtrostat (GNS561) and dimeric chloroquine (DC661), promising heralds in palmitoylation-targeted cancer therapy. Collectively, this review accentuates palmitoylation's transformative potential in oncology, foreshadowing groundbreaking therapeutic strategies and deepening our molecular comprehension of cancer dynamics.
Insights
Palmitoylation plays a key role in cancer cell death and growth. New therapies targeting palmitoylation, like Ezurpimtrostat, show promise for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Palmitoylation, a lipid modification, is increasingly recognized for its role in cancer progression and cell death.
- The DHHC enzyme family and depalmitoylation enzymes like PPT1 are critical regulators of palmitoylation.
- Advances in detection methods have improved the study of palmitoylation dynamics.
Purpose of the Study:
- To comprehensively review the role of palmitoylation in various cancer cell death pathways.
- To explore the connection between palmitoylation, tumorigenesis, and depalmitoylation.
- To highlight novel therapeutic agents targeting palmitoylation in cancer.
Main Methods:
- Literature review of existing studies on palmitoylation in oncology.
- Analysis of the mechanisms involving DHHC enzymes and depalmitoylation.
- Discussion of emerging therapeutic agents and detection methodologies.
Main Results:
- Palmitoylation is intricately linked to tumorigenesis and diverse cell death modalities.
- DHHC enzymes catalyze palmitoylation, while enzymes like PPT1 mediate depalmitoylation.
- Ezurpimtrostat (GNS561) and dimeric chloroquine (DC661) represent promising therapeutic strategies.
Conclusions:
- Palmitoylation is a critical regulator of cancer cell fate with significant therapeutic potential.
- Targeting palmitoylation pathways offers a novel approach for cancer treatment.
- Further research into palmitoylation dynamics will deepen our understanding of cancer biology.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
PI3K/mTOR/AKT Signaling Pathway
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

